Inside the Phase 3 BREAKWATER Trial: First-Line BRAF V600E-Mutant Metastatic Colorectal Cancer
ASCO 2026 data highlight rising early-onset cancers, prompting earlier screening, genomic testing, fertility-focused care, and heightened suspicion as diagnoses increasingly affect younger adults worldwide today.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.